Avantor, Inc. ($AVTR) Stock Forecast: Down 5.0% Today

What is Avantor, Inc.?

Avantor (NYSE: AVTR) is a company that serves customers in various sectors like biopharma, healthcare, education, and government. The company's stock experienced significant downward movement in the market today.

Why is Avantor, Inc. going down?

AVTR stock is down 5.0% on Mar 12, 2026 18:35

• The decline in Avantor's stock price may be linked to an ongoing securities investigation, potentially causing concerns among investors regarding the company's integrity.
• Despite recent insider purchases and increased stakes by institutional investors such as Barrow Hanley Mewhinney & Strauss LLC and American Century Companies Inc., the negative impact of the investigation news likely overshadowed these positive events.
• The market sentiment might have been influenced by differing analyst ratings, with an overall "Hold" consensus on Avantor, indicating a lack of strong buy recommendations that could have bolstered investor trust.
• While there was a notable rise in institutional ownership, including significant share acquisitions by WINTON GROUP Ltd, this positive development may have been outweighed by the lingering impact of the ongoing investigation, leading to the stock's bearish trend.

AVTR Price Chart

AVTR Technical Analysis

AVTR News

Insider Buying: Avantor (NYSE:AVTR) Director Buys 125,000 Shares of Stock

Avantor (NYSE:AVTR) Director Sanjeev Mehra recently purchased 125,000 shares of the company's stock for over $1 million, increasing his direct holdings to 475,000 shares. This transaction comes as Avantor's stock shows a slight increase, trading at $8.32, with the company having recently beaten quarterly EPS estimates and provided its FY2026 guidance. Despite a negative net margin, institutional ownership in Avantor is robust, accounting for about 95% of its shares.

https://www.marketbeat.com/instant-alerts/insider-buying-avantor-nyseavtr-director-buys-125000-shares-of-stock-2026-03-11/

Barrow Hanley Mewhinney & Strauss LLC Has $431.16 Million Stock Holdings in Avantor, Inc. $AVTR

Barrow Hanley Mewhinney & Strauss LLC significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 10.8% in the third quarter, bringing their total holdings to $431.16 million, representing 5.07% of the company's stock. Other institutional investors also adjusted their holdings, with several new positions established. Despite varied analyst ratings, insider transactions show directors accumulating more shares, indicating confidence in the company.

https://www.marketbeat.com/instant-alerts/filing-barrow-hanley-mewhinney-strauss-llc-has-43116-million-stock-holdings-in-avantor-inc-avtr-2026-03-11/

American Century Companies Inc. Purchases New Holdings in Avantor, Inc. $AVTR

American Century Companies Inc. has acquired a significant new position in Avantor, Inc. (NYSE:AVTR), purchasing 1,524,991 shares valued at approximately $19.03 million during the third quarter. This acquisition makes American Century Companies Inc. one of several institutional investors to adjust their holdings in Avantor recently. The article also details Avantor's financial performance, recent insider trading activity, and current analyst ratings, with a consensus "Hold" rating and a target price of $11.80.

https://www.marketbeat.com/instant-alerts/filing-american-century-companies-inc-purchases-new-holdings-in-avantor-inc-avtr-2026-03-11/

Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased securities of Avantor, Inc. (AVTR) before March 5, 2024. The investigation concerns possible corporate wrongdoing by Avantor and its officers. Investors are encouraged to visit the firm's website or contact them for more information and to assist with the investigation, with no cost to the investors.

https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-encourages-avantor-inc.-avtr-1143222

WINTON GROUP Ltd Buys 363,928 Shares of Avantor, Inc. $AVTR

WINTON GROUP Ltd significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 797.6% in the third quarter, now owning 409,558 shares valued at $5.11 million. This move is part of a broader trend of institutional investors modifying their holdings in Avantor. Additionally, the article highlights recent insider purchases by directors Gregory T. Lucier and Gregory L. Summe, showing their increased confidence in the company.

https://www.marketbeat.com/instant-alerts/filing-winton-group-ltd-buys-363928-shares-of-avantor-inc-avtr-2026-03-10/

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.3% Today

Avantor, Inc. Price History

15.00.2026 - AVTR Stock was down 6.3%

• The decrease in Avantor's stock price might be linked to Pacific Capital Partners Ltd's substantial sell-off, resulting in a 22.5% reduction in its holdings.
• Despite recent insider purchases and significant institutional ownership, the decrease in Pacific Capital Partners Ltd's position could have influenced negative market sentiment.
• The anticipation surrounding the upcoming earnings announcement for the fourth quarter and full year of 2025 may be prompting investors to reassess their positions, contributing to the bearish trend.
• Falling slightly short of the quarterly EPS and revenue targets could also have played a role in adding downward pressure on the stock.

29.00.2026 - AVTR Stock was down 5.2%

• The bearish movement in AVTR's stock price today can be attributed to several factors:
• Allegations of misrepresentation and increased competition leading to a federal securities lawsuit may have raised concerns among investors, impacting the stock negatively.
• Insider purchases by Sector Gamma AS and two directors, while initially positive, were overshadowed by Avantor missing its quarterly EPS estimates and providing lower-than-expected guidance for FY2025.
• The upcoming release of Q4 and full-year 2025 financial results, along with discussions on the outlook for 2026, has likely created uncertainty and caution among investors, contributing to the bearish sentiment.
• The ongoing investigations by multiple law firms into potential breaches of fiduciary duties by Avantor's officers and directors have added to the negative sentiment surrounding the stock, further pressuring its price downwards.

10.11.2025 - AVTR Stock was up 5.5%

• The bullish movement in AVTR's stock today could be attributed to investors' optimism or confidence in the company's ability to navigate through the ongoing legal challenges and emerge successfully.
• Despite the pending class action lawsuits and allegations of securities fraud, investors might be focusing on the long-term growth prospects of the company and its resilience in the face of competitive pressures.
• The market movement could also indicate that investors believe AVTR will address the issues raised in the lawsuits effectively, leading to a positive outlook for the company's future performance.
• It is essential for investors to carefully monitor any developments related to the legal proceedings and assess their potential impact on AVTR's stock in the coming days.

05.00.2026 - AVTR Stock was up 2.2%

• The bullish movement in AVTR stock today can be attributed to increased confidence shown by institutional investors and insiders through significant share purchases.
• Avantor's participation in the 44th Annual J.P. Morgan Healthcare Conference might have sparked investor interest and optimism in the company's future prospects.
• Despite the stock trading near its 52-week low and recent earnings misses, substantial investments by funds like Kinney Asset Management and Olstein Capital Management suggest a belief in the company's potential turnaround.
• The combination of insider buying, institutional investments, and participation in key events are indicative of a positive sentiment shift towards Avantor, potentially driving the bullish movement in the stock today.

06.02.2026 - AVTR Stock was down 6.1%

• An "underweight" rating on Avantor reiterated by Barclays reflects concerns about future earnings, despite the company surpassing recent earnings expectations slightly. This negative sentiment from analysts may have influenced the stock's bearish movement.
• The negative forecast for Avantor's Q1 2026 earnings by Zacks Research, along with multiple analysts lowering price targets, has added pressure on the stock.
• Despite a high institutional ownership, the significant decrease in stake by the Teachers Retirement System of The State of Kentucky might suggest a lack of confidence in Avantor's future prospects, further impacting the stock price negatively.
• Avantor's historical poor earnings performance, continuously missing EPS and revenue estimates, along with ongoing financial challenges such as low return on equity and declining net profit, have likely heightened investor worries and contributed to the stock reaching a new low.

14.00.2026 - AVTR Stock was down 1.1%

• Today, Avantor (AVTR) experienced a strong bearish movement in the stock market, likely influenced by the following factors:
• The announcement of the upcoming release of Avantor's fourth quarter and full-year 2025 financial results may have created uncertainty among investors, leading to a sell-off of shares in anticipation of the report.
• The partnership with p-Chip Corporation, Choice One Rx, and RxERP to launch a trial demonstrating digital traceability of drug supply chains could have raised concerns about potential costs or challenges associated with implementing new technologies.
• Despite Avantor's CEO presenting at the J.P. Morgan Healthcare Conference and highlighting the company's strategic positioning in the life sciences industry, investors may have focused more on short-term financial performance, contributing to the bearish market movement.

11.01.2026 - AVTR Stock was down 16.5%

• An investigation into potential corporate wrongdoing by Avantor and its officers/directors may have caused concerns among investors, resulting in a sell-off.
• Analysts' expectation of a 2.9% year-over-year revenue decrease in the upcoming earnings report could have influenced the negative sentiment towards the stock.
• Bessemer Group Inc.'s significant reduction in its stake in Avantor, Inc. by selling over 7 million shares likely exacerbated the downward pressure on the stock.
• Avantor's history of underperforming in revenue estimates compared to the sector may have prompted investors to approach the stock cautiously, leading to today's bearish movement.

06.00.2026 - AVTR Stock was up 6.5%

• Institutional investors like VIRGINIA RETIREMENT SYSTEMS ET Al and company directors Gregory L. Summe and Sanjeev K. Mehra have been actively purchasing AVTR stock, showcasing confidence in its future.
• Avantor's participation in the 44th Annual J.P. Morgan Healthcare Conference is likely boosting investor confidence, offering a platform for the company to exhibit its products.
• Despite recent challenges like a significant stock price decline and a Q3 earnings miss, increased investment from Kinney Asset Management and their support for Avantor's potential turnaround through a new share repurchase program could be driving optimism among investors, leading to the current bullish trend.

21.10.2025 - AVTR Stock was up 5.2%

• The bullish movement in AVTR's stock price today could be attributed to the following factors:
• Despite facing pending class action lawsuits, investors may have gained confidence in the company's ability to navigate through legal challenges.
• The upcoming deadline for shareholders to file motions in the class action lawsuits might have led to increased trading activity and speculation in the stock.
• Investors might be optimistic about AVTR's future prospects or potential resolutions to the legal issues, driving the stock price higher.
• Market sentiment surrounding AVTR could have been positively influenced by external factors such as industry trends or broader market conditions, contributing to the bullish movement.

28.00.2026 - AVTR Stock was down 5.2%

• Sector Gamma AS increased its stake in Avantor, Inc., and two directors made insider purchases, but the company missed its quarterly EPS estimates and provided lower-than-expected guidance, leading to a consensus "Hold" rating and a decrease in stock value.
• Investors are eagerly awaiting Avantor's Q4 and full-year 2025 financial results, as well as insights into the company's 2026 financial outlook. Uncertainty surrounding these upcoming announcements may have contributed to the bearish market movement.
• Avantor has been recognized as a significant player in lab infrastructure, supplying essential materials for various industries, which presents a positive long-term investment outlook. However, the discrepancy between market expectations and the company's recent performance could have influenced today's bearish trend.

12.01.2026 - AVTR Stock was down 5.2%

• AVTR stock plummeted post-Q4 earnings disclosure due to the conservative 2026 forecast and a Q4 revenue decline.
• The company's "Revival" initiative aimed at enhancing manufacturing, supply chain, and digital platforms did not capture investor interest, resulting in subdued market sentiment and a stock dip.
• An uptick in put options trading, signaling potential higher volatility or downside for AVTR stock, showcases mixed investor sentiment.
• Despite favorable financial performance, including surpassing earnings expectations and a significant insider buy-in, apprehensions regarding future guidance and market conditions contributed to the downward movement in AVTR stock.

12.02.2026 - AVTR Stock was down 5.0%

• The decline in Avantor's stock price may be linked to an ongoing securities investigation, potentially causing concerns among investors regarding the company's integrity.
• Despite recent insider purchases and increased stakes by institutional investors such as Barrow Hanley Mewhinney & Strauss LLC and American Century Companies Inc., the negative impact of the investigation news likely overshadowed these positive events.
• The market sentiment might have been influenced by differing analyst ratings, with an overall "Hold" consensus on Avantor, indicating a lack of strong buy recommendations that could have bolstered investor trust.
• While there was a notable rise in institutional ownership, including significant share acquisitions by WINTON GROUP Ltd, this positive development may have been outweighed by the lingering impact of the ongoing investigation, leading to the stock's bearish trend.